Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Recent findings in breast cancer described by P. Francis and colleagues
April 3rd, 2008
" Docetaxel is more effective than doxorubicin for patients with advanced breast cancer. The Breast International Group 02-98 randomized trial tested the effect of incorporating docetaxel into anthracycline-based adjuvant chemotherapy and compared sequential vs concurrent administration of doxorubicin and docetaxel," researchers in Melbourne, Australia report. " Patients with lymph node - positive breast cancer ( n = 2887) were randomly assigned to one of four treatments: 1) sequential control ( four cycles of doxorubicin at 75 mg/ m(2), followed by three cycles of cyclophosphamide, methotrexate, and 5-fluorouracil [CMF]); 2) concurrent control (four cycles of...
Source: Women's Health Weekly (2008-04-03)
|
